Hardware, Equipment & Parts
Compare Stocks
5 / 10Stock Comparison
MKSI vs NVDA vs AMAT vs KLAC vs LRCX
Revenue, margins, valuation, and 5-year total return — side by side.
Semiconductors
Semiconductors
Semiconductors
Semiconductors
MKSI vs NVDA vs AMAT vs KLAC vs LRCX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Hardware, Equipment & Parts | Semiconductors | Semiconductors | Semiconductors | Semiconductors |
| Market Cap | $20.25B | $5.14T | $325.54B | $231.68B | $357.66B |
| Revenue (TTM) | $4.07B | $215.94B | $28.37B | $13.10B | $21.68B |
| Net Income (TTM) | $327M | $120.07B | $7.00B | $4.67B | $6.71B |
| Gross Margin | 45.2% | 71.1% | 48.7% | 61.8% | 50.0% |
| Operating Margin | 14.8% | 60.4% | 29.2% | 42.1% | 34.3% |
| Forward P/E | 30.4x | 25.6x | 37.1x | 47.9x | 50.7x |
| Total Debt | $4.69B | $11.41B | $6.55B | $6.09B | $4.76B |
| Cash & Equiv. | $675M | $10.61B | $7.24B | $2.08B | $6.39B |
MKSI vs NVDA vs AMAT vs KLAC vs LRCX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| MKS Inc. (MKSI) | 100 | 284.8 | +184.8% |
| NVIDIA Corporation (NVDA) | 100 | 2381.7 | +2281.7% |
| Applied Materials, … (AMAT) | 100 | 730.7 | +630.7% |
| KLA Corporation (KLAC) | 100 | 1002.1 | +902.1% |
| Lam Research Corpor… (LRCX) | 100 | 1046.4 | +946.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MKSI vs NVDA vs AMAT vs KLAC vs LRCX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MKSI is the #2 pick in this set and the best alternative if momentum is your priority.
- +306.1% vs NVDA's +80.7%
NVDA carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 65.5%, EPS growth 66.7%, 3Y rev CAGR 100.0%
- 239.0% 10Y total return vs LRCX's 38.2%
- Lower volatility, beta 1.73, Low D/E 7.3%, current ratio 3.91x
- PEG 0.27 vs LRCX's 2.26
AMAT ranks third and is worth considering specifically for income & stability.
- Dividend streak 8 yrs, beta 2.14, yield 0.4%
- 0.4% yield, 8-year raise streak, vs LRCX's 0.3%
KLAC lags the leaders in this set but could rank higher in a more targeted comparison.
Among these 5 stocks, LRCX doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 65.5% revenue growth vs AMAT's 4.4% | |
| Value | Lower P/E (25.6x vs 50.7x), PEG 0.27 vs 2.26 | |
| Quality / Margins | 55.6% margin vs MKSI's 8.0% | |
| Stability / Safety | Beta 1.73 vs MKSI's 2.64, lower leverage | |
| Dividends | 0.4% yield, 8-year raise streak, vs LRCX's 0.3% | |
| Momentum (1Y) | +306.1% vs NVDA's +80.7% | |
| Efficiency (ROA) | 58.1% ROA vs MKSI's 3.7%, ROIC 81.8% vs 6.5% |
MKSI vs NVDA vs AMAT vs KLAC vs LRCX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
MKSI vs NVDA vs AMAT vs KLAC vs LRCX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
NVDA leads in 4 of 6 categories
MKSI leads 1 • AMAT leads 0 • KLAC leads 0 • LRCX leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
NVDA leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NVDA is the larger business by revenue, generating $215.9B annually — 53.0x MKSI's $4.1B. NVDA is the more profitable business, keeping 55.6% of every revenue dollar as net income compared to MKSI's 8.0%. On growth, NVDA holds the edge at +73.2% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $4.1B | $215.9B | $28.4B | $13.1B | $21.7B |
| EBITDAEarnings before interest/tax | $945M | $133.2B | $8.4B | $5.9B | $7.8B |
| Net IncomeAfter-tax profit | $327M | $120.1B | $7.0B | $4.7B | $6.7B |
| Free Cash FlowCash after capex | $401M | $96.7B | $5.7B | $4.0B | $6.5B |
| Gross MarginGross profit ÷ Revenue | +45.2% | +71.1% | +48.7% | +61.8% | +50.0% |
| Operating MarginEBIT ÷ Revenue | +14.8% | +60.4% | +29.2% | +42.1% | +34.3% |
| Net MarginNet income ÷ Revenue | +8.0% | +55.6% | +24.7% | +35.7% | +30.9% |
| FCF MarginFCF ÷ Revenue | +9.8% | +44.8% | +20.1% | +30.7% | +29.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.2% | +73.2% | -3.5% | +11.5% | +23.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +53.2% | +97.8% | +13.9% | +11.8% | +40.8% |
Valuation Metrics
MKSI leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 43.2x trailing earnings, NVDA trades at a 37% valuation discount to LRCX's 69.0x P/E. Adjusting for growth (PEG ratio), NVDA offers better value at 0.45x vs LRCX's 3.08x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $20.2B | $5.14T | $325.5B | $231.7B | $357.7B |
| Enterprise ValueMkt cap + debt − cash | $24.3B | $5.14T | $324.9B | $235.7B | $356.0B |
| Trailing P/EPrice ÷ TTM EPS | 68.83x | 43.16x | 47.40x | 58.06x | 69.01x |
| Forward P/EPrice ÷ next-FY EPS est. | 30.36x | 25.55x | 37.07x | 47.92x | 50.65x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.45x | 2.76x | 1.84x | 3.08x |
| EV / EBITDAEnterprise value multiple | 26.70x | 38.59x | 38.68x | 41.82x | 56.63x |
| Price / SalesMarket cap ÷ Revenue | 5.15x | 23.80x | 11.48x | 19.06x | 19.40x |
| Price / BookPrice ÷ Book value/share | 7.49x | 32.85x | 16.25x | 50.26x | 37.47x |
| Price / FCFMarket cap ÷ FCF | 40.74x | 53.17x | 57.13x | 61.92x | 66.06x |
Profitability & Efficiency
NVDA leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
KLAC delivers a 89.1% return on equity — every $100 of shareholder capital generates $89 in annual profit, vs $12 for MKSI. NVDA carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to MKSI's 1.73x. On the Piotroski fundamental quality scale (0–9), KLAC scores 9/9 vs NVDA's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +12.2% | +76.3% | +34.3% | +89.1% | +65.8% |
| ROA (TTM)Return on assets | +3.7% | +58.1% | +19.3% | +28.3% | +31.4% |
| ROICReturn on invested capital | +6.5% | +81.8% | +33.3% | +46.5% | +55.7% |
| ROCEReturn on capital employed | +7.2% | +97.2% | +30.6% | +46.1% | +40.4% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 | 7 | 9 | 8 |
| Debt / EquityFinancial leverage | 1.73x | 0.07x | 0.32x | 1.30x | 0.48x |
| Net DebtTotal debt minus cash | $4.0B | $807M | -$686M | $4.0B | -$1.6B |
| Cash & Equiv.Liquid assets | $675M | $10.6B | $7.2B | $2.1B | $6.4B |
| Total DebtShort + long-term debt | $4.7B | $11.4B | $6.6B | $6.1B | $4.8B |
| Interest CoverageEBIT ÷ Interest expense | 2.84x | 545.03x | 35.46x | 19.38x | 58.92x |
Total Returns (Dividends Reinvested)
NVDA leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in NVDA five years ago would be worth $142,893 today (with dividends reinvested), compared to $16,648 for MKSI. Over the past 12 months, MKSI leads with a +306.1% total return vs NVDA's +80.7%. The 3-year compound annual growth rate (CAGR) favors NVDA at 93.6% vs AMAT's 53.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +78.8% | +12.0% | +52.9% | +38.5% | +54.9% |
| 1-Year ReturnPast 12 months | +306.1% | +80.7% | +164.7% | +155.0% | +282.9% |
| 3-Year ReturnCumulative with dividends | +266.0% | +625.9% | +258.7% | +364.8% | +448.8% |
| 5-Year ReturnCumulative with dividends | +66.5% | +1328.9% | +213.8% | +460.4% | +360.5% |
| 10-Year ReturnCumulative with dividends | +750.6% | +23902.3% | +2014.4% | +2511.9% | +3815.1% |
| CAGR (3Y)Annualised 3-year return | +54.1% | +93.6% | +53.1% | +66.9% | +76.4% |
Risk & Volatility
NVDA leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
NVDA is the less volatile stock with a 1.73 beta — it tends to amplify market swings less than MKSI's 2.64 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NVDA currently trades 97.6% from its 52-week high vs KLAC's 90.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.64x | 1.73x | 2.14x | 2.20x | 2.54x |
| 52-Week HighHighest price in past year | $326.83 | $216.80 | $432.81 | $1939.36 | $298.00 |
| 52-Week LowLowest price in past year | $71.49 | $112.28 | $151.51 | $675.27 | $72.91 |
| % of 52W HighCurrent price vs 52-week peak | +92.0% | +97.6% | +94.8% | +90.9% | +96.1% |
| RSI (14)Momentum oscillator 0–100 | 65.3 | 60.7 | 66.3 | 59.1 | 69.9 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 164.5M | 6.0M | 971K | 9.7M |
Analyst Outlook
Evenly matched — AMAT and LRCX each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MKSI as "Buy", NVDA as "Buy", AMAT as "Buy", KLAC as "Buy", LRCX as "Buy". Consensus price targets imply 31.8% upside for NVDA (target: $279) vs -9.3% for MKSI (target: $273). For income investors, AMAT offers the higher dividend yield at 0.42% vs MKSI's 0.29%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $272.86 | $278.83 | $426.39 | $1819.38 | $290.65 |
| # AnalystsCovering analysts | 29 | 79 | 53 | 44 | 50 |
| Dividend YieldAnnual dividend ÷ price | +0.3% | +0.0% | +0.4% | +0.4% | +0.3% |
| Dividend StreakConsecutive years of raises | 0 | 2 | 8 | 8 | 11 |
| Dividend / ShareAnnual DPS | $0.87 | $0.04 | $1.71 | $6.76 | $0.89 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +0.8% | +1.5% | +0.9% | +1.0% |
NVDA leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MKSI leads in 1 (Valuation Metrics). 1 tied.
MKSI vs NVDA vs AMAT vs KLAC vs LRCX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MKSI or NVDA or AMAT or KLAC or LRCX a better buy right now?
For growth investors, NVIDIA Corporation (NVDA) is the stronger pick with 65.
5% revenue growth year-over-year, versus 4. 4% for Applied Materials, Inc. (AMAT). NVIDIA Corporation (NVDA) offers the better valuation at 43. 2x trailing P/E (25. 6x forward), making it the more compelling value choice. Analysts rate MKS Inc. (MKSI) a "Buy" — based on 29 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MKSI or NVDA or AMAT or KLAC or LRCX?
On trailing P/E, NVIDIA Corporation (NVDA) is the cheapest at 43.
2x versus Lam Research Corporation at 69. 0x. On forward P/E, NVIDIA Corporation is actually cheaper at 25. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: NVIDIA Corporation wins at 0. 27x versus Lam Research Corporation's 2. 26x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MKSI or NVDA or AMAT or KLAC or LRCX?
Over the past 5 years, NVIDIA Corporation (NVDA) delivered a total return of +1329%, compared to +66.
5% for MKS Inc. (MKSI). Over 10 years, the gap is even starker: NVDA returned +239. 0% versus MKSI's +750. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MKSI or NVDA or AMAT or KLAC or LRCX?
By beta (market sensitivity over 5 years), NVIDIA Corporation (NVDA) is the lower-risk stock at 1.
73β versus MKS Inc. 's 2. 64β — meaning MKSI is approximately 53% more volatile than NVDA relative to the S&P 500. On balance sheet safety, NVIDIA Corporation (NVDA) carries a lower debt/equity ratio of 7% versus 173% for MKS Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — MKSI or NVDA or AMAT or KLAC or LRCX?
By revenue growth (latest reported year), NVIDIA Corporation (NVDA) is pulling ahead at 65.
5% versus 4. 4% for Applied Materials, Inc. (AMAT). On earnings-per-share growth, the picture is similar: NVIDIA Corporation grew EPS 66. 7% year-over-year, compared to 0. 6% for Applied Materials, Inc.. Over a 3-year CAGR, NVDA leads at 100. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MKSI or NVDA or AMAT or KLAC or LRCX?
NVIDIA Corporation (NVDA) is the more profitable company, earning 55.
6% net margin versus 7. 5% for MKS Inc. — meaning it keeps 55. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: NVDA leads at 60. 4% versus 14. 4% for MKSI. At the gross margin level — before operating expenses — NVDA leads at 71. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MKSI or NVDA or AMAT or KLAC or LRCX more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, NVIDIA Corporation (NVDA) is the more undervalued stock at a PEG of 0. 27x versus Lam Research Corporation's 2. 26x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, NVIDIA Corporation (NVDA) trades at 25. 6x forward P/E versus 50. 7x for Lam Research Corporation — 25. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for NVDA: 31. 8% to $278. 83.
08Which pays a better dividend — MKSI or NVDA or AMAT or KLAC or LRCX?
In this comparison, AMAT (0.
4% yield), KLAC (0. 4% yield), LRCX (0. 3% yield), MKSI (0. 3% yield) pay a dividend. NVDA does not pay a meaningful dividend and should not be held primarily for income.
09Is MKSI or NVDA or AMAT or KLAC or LRCX better for a retirement portfolio?
For long-horizon retirement investors, MKS Inc.
(MKSI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (+750. 6% 10Y return). Applied Materials, Inc. (AMAT) carries a higher beta of 2. 14 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MKSI: +750. 6%, AMAT: +20. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MKSI and NVDA and AMAT and KLAC and LRCX?
Both stocks operate in the Technology sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MKSI is a mid-cap quality compounder stock; NVDA is a mega-cap high-growth stock; AMAT is a large-cap quality compounder stock; KLAC is a large-cap high-growth stock; LRCX is a large-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.